Skip to main content
. Author manuscript; available in PMC: 2018 Aug 1.
Published in final edited form as: Diabetologia. 2017 May 20;60(8):1442–1453. doi: 10.1007/s00125-017-4303-6

Fig. 5.

Fig. 5

Effects of chronic GLP-1 signalling activation on beta cell lines. (a) Western blotting or βIRKO mouse beta cells and control beta cells (LoxLoxβ) for total and p-Akt, CDK2, CDK4, cyclin A, cyclin D1, cyclin D2 and cyclin E with or without 24 h stimulation with 10 nmol/l Ex-4. Representative images of three independent experiments are shown. (b) Relative expression of proteins compared with non-stimulated state. Expression was normalised to actin except for p-Akt which was normalised to total Akt. White bars, control; black bars, Ex-4-treated. All data are expressed as mean ± SEM. n=3 in each group. *p<0.05, **p<0.01, Ex-4-treated vs control